The FDA Law Blog

DECEMBER 11, 2023

Mullen — With comments due on the proposed LDT rule last week, FDA wasted no time updating the Unified Agenda to indicate that a final rule may be published in April ( here ). Under the Administrative Procedure Act, FDA is obligated to address major substantive issues when – and not so much if – it publishes a final rule.

FDA 69

FDA Research Laboratories Documentation 69

The People's Pharmacy

MAY 8, 2023

Why, then, are FDA inspections abroad so infrequent and disappointing? FDA Inspections Suspended: During the COVID pandemic, the Food and Drug Administration suspended its inspections at most foreign pharmaceutical facilities. Even under the best of conditions, the FDA never inspects all foreign pharmaceutical plants annually.

FDA 72

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools 72

The FDA Law Blog

SEPTEMBER 11, 2023

Lenz, Principal Medical Device Regulation Expert — On September 6, 2023, FDA announced its latest efforts to modernize the 510(k) process, outlining FDA’s latest improvements to strengthen the 510(k) Program and announcing release of three draft guidance documents. stated, “ We appreciate the IOM’s report on the 510(k) program.

Documentation 64

Documentation FDA 64

ISPE

MARCH 23, 2023

A True Copy is an exact copy of original documentation that preserves the same content, meaning and attributes of the original. It is an electronic copy maintained in an electronic document management system. This negates the requirement for storage of paper evidence and correct GMP document management of these hardcopy evidences.

Documentation 98

Documentation FDA 98

The FDA Law Blog

SEPTEMBER 26, 2022

Brevig, Senior Regulatory Device and Biologics Exper — FDA recently published Alternative or Streamlined Mechanisms for Complying with the Current Good Manufacturing Practice Requirements for Combination Products; List under the 21st Century Cures Act in the Federal Register (FR Notice). FDA must also review the list periodically.

FDA 40

FDA Documentation Medication Dispensing Packaging 40

pharmaphorum

AUGUST 31, 2021

The industry has looked to regulators for guidance, and the Food and Drug Administration (FDA) has been quick to respond. Within this framework, the FDA seeks to answer outstanding questions on how it will ultimately assess RWD, as well as address any prospective issues, such as cohort bias and data quality.

FDA 89

FDA Insurance Coverage Documentation Pharmaceutical Companies 89

pharmaphorum

SEPTEMBER 21, 2020

Waylivra – its second drug – was rejected by the FDA in 2018 on concerns about its safety, including the risk of serious bleeding and low blood platelet count. Fantatic news for the FCS Community – NICE has issued a positive Final Evaluation Document (FED) for Volanesorsen.

Documentation 80

Documentation FDA 80

pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. These teams will include experts in regulatory, GMP compliance and quality systems, often including ex-FDA and MHRA inspectors and industry experts.

Documentation 119

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 119

The FDA Law Blog

OCTOBER 5, 2022

eSTAR employs targeted questions to collect specific data and information and includes applicable links to regulations, relevant guidance documents, and other resources. This has the potential to make the FDA’s review efficient as relevant information is collected upfront. printing to PDF) that states comments will not be sent to FDA.

Documentation 45

Documentation FDA 45

pharmaphorum

JULY 27, 2022

In addition, the median time between regulatory approval and the first patient receiving a first dose was 247 days in 2020 – an increase of 25 days since 2018. The news comes weeks after researchers found patients across Europe were already waiting longer than their American counterparts for access to new cancer drugs.

Documentation 98

Documentation FDA 98

pharmaphorum

DECEMBER 29, 2022

The FDA granted full approval to Par’s generic on 28 March, 2013. Plaintiffs – in this case direct purchasers, indirect purchasers and retailers including CVS Health, Kroger, Rite Aid and Walgreens Boots Alliance according to Reuters – filed suit against Novartis and Par in 2018 alleging violation of federal antitrust laws.

Specialty Pharmacies 52

Specialty Pharmacies Documentation FDA 52

pharmaphorum

SEPTEMBER 29, 2022

In the United States, the Food and Drug Administrator (FDA) has so far published three draft guidance documents on patient-focused drug development, with a fourth expected in the coming months. EMA and FDA backing represents a huge step forward for patient centricity as a force for good in pharmaceutical development.

Documentation 98

Documentation FDA 98

pharmaphorum

JANUARY 4, 2022

The FDA subsequently raised serious concerns about the accuracy of testing that Theranos did conduct with its machines, and the company eventually retracted two years of blood tests. It eventually folded in 2018.

Documentation 52

Documentation Communication FDA 52

pharmaphorum

MARCH 4, 2021

Lilly’s drug becomes an oral alternative to Sanofi and Regeneron’s biologic therapy Dupixent (dupilumab), which was recommended as a second-line option for moderate to severe atopic dermatitis in 2018. Dupilumab does not always work, and some people stop taking it because of side effects,” according to NICE’s technical appraisal document.

Documentation 52

Documentation FDA 52

The Checkup by Singlecare

DECEMBER 1, 2023

Food and Drug Administration (FDA) certifies the Red Dye 40 as safe for human consumption. Apart from Red Dye 40, there are eight other certified color additives approved for use in food by the FDA: Blue No. The FDA has denied any link between the two for years. The controversy surrounding Red Dye 40 The U.S. 1, Blue No.

Labelling 52

Labelling FDA Documentation 52

ISPE

JULY 6, 2023

Q13 Development Timeline The process of drafting the new guidance document was initiated in earnest in November 2018 when the concept paper 2 and business plan were endorsed. Since then, agencies have begun officially adopting the guidance, with the FDA doing so in March 2023.

Documentation 52

Documentation FDA Dosage Pharmaceutical Companies 52

The FDA Law Blog

FEBRUARY 27, 2023

Comment topics suggested by DEA include the following: Whether the rule should limit the issuance of prescriptions for controlled medications to FDA-approved indications contained in the labeling for those medications. The only schedule III-V narcotic drug that is currently approved by the FDA for OUD treatment is buprenorphine.

Controlled Substances 59

Controlled Substances FDA Documentation Communication 59

The Checkup by Singlecare

JANUARY 13, 2025

However, the Food and Drug Administration (FDA) didnt officially approve Basaglar as a biosimilar, but rather a follow-on insulin essentially one companys copy of another companys product. Lantus has two FDA-approved biosimilars : Semglee and Rezvoglar.

Insurance 52

Insurance Insurance Coverage Dosage Documentation 52

ISPE

MAY 11, 2023

The FDA, PIC/S, and WHO have all emphasized the importance and benefits of data flows in their guidance on data integrity. 3 , 4 RAMI integrates all assets, including physical items, software, administrative shell, documents, and personnel. Many organizations already have documented process maps. Figure 3 shows all four steps.

Packaging 52

Packaging Documentation Communication Data Entry 52

The Thyroid Pharmacist

JULY 14, 2023

9] A follow-up study done in 2018 (also led by Hofling) assessed the same group of 43 people six years after the clinical trial. All Lumebox products are FDA-registered, follow the Good Manufacturing Practice (GMP) system, and every batch is third-party tested. Published 2018 Nov 4. References [1] Nanan R, Wall JR.

Dosage 98

Dosage FDA Immunization Documentation 98

The FDA Law Blog

JUNE 16, 2023

We expect the Minnesota law to face Commerce Clause, vagueness, and possibly other constitutional challenges, similar to those brought against a generic price gouging prohibition in Maryland that was struck down by the Fourth Circuit in 2018 (see our post here ).

Documentation 45

Documentation Dosage Labelling 45

ISPE

JULY 10, 2023

However, when the US Food and Drug Administration (FDA) introduced “Pharmaceutical cGMPs for the 21st Century — A Risk-Based Approach” 5 in September 2004, the paradigm shifted and these questions were asked: What is the probability that changing the airflow in a given clean area will affect the process or product in that area? 241,110 16.6

Documentation 52

Documentation FDA 52

ISPE

MARCH 29, 2023

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” As part of the US Food and Drug Administration (FDA) QbD pilot 4 in 2005–2006, the need to convey how the control strategy is linked to the target product profile (TPP) and quality target product profile (QTPP) was discussed. The authors propose using Module 2.3

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” As part of the US Food and Drug Administration (FDA) QbD pilot 4 in 2005–2006, the need to convey how the control strategy is linked to the target product profile (TPP) and quality target product profile (QTPP) was discussed. The authors propose using Module 2.3

Documentation 52

Documentation Dosage Packaging Communication 52

The FDA Law Blog

JANUARY 4, 2023

When FDA published its draft guidance on payor communications in 2017, it seemed revolutionary – introducing the concept of pre-approval information exchange for wholly unapproved products. FDA had put industry in a quandary.

Communication 64

Communication FDA Labelling Documentation 64

The FDA Law Blog

OCTOBER 17, 2023

FDA previously released the final guidance document in December 2018 outlining the program’s principles, features, designation criteria, and other considerations. Additionally, the 2022 draft guidance suggested the addition of a new section to the 2018 guidance on reducing disparities in health and healthcare.

Documentation 53

Documentation FDA Medication Dispensing Hospitals 53

ISPE

NOVEMBER 3, 2022

The regulatory keynote was delivered by Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research (CBER), US FDA. Marks outlined some concepts that the FDA is thinking about that could help move in this direction, such as developing a “cookbook” to standardize bespoke product development and manufacturing.

Communication 98

Communication FDA Documentation Vaccines 98

ISPE

JANUARY 8, 2023

Building on these concepts, we provide insights and guidance on how to effectively support the “Human-AI-Team,” a term of the FDA 5 we believe describes very well the target operating model when interacting with AI: in a collaborative manner, complementing the strengths of cognitive as well as AI in GxP-related areas. 12 November 2018.

Communication 52

Communication Documentation FDA 52

The FDA Law Blog

JUNE 19, 2023

Cato — The long-running saga of FDA regulation of laboratory-developed tests (LDTs) has taken yet another new turn. Take for example FDA’s Unified Agenda announcement for ISO 13485 harmonization, which first occurred in the Spring of 2018 and was re-issued until a proposed rule was published in early 2022 (see our post here ).

FDA 56

FDA Documentation 56

ISPE

OCTOBER 28, 2022

It was usual practice for TGA to prepare additional guidance/explanatory documents for industry and for TGA inspection staff to participate in training seminars to assist industry. Paul indicated that in 2018, ICMRA introduced an Inspection Reliance Guideline which was adopted by PIC/S ( PICS Inspection Reliance Guidance ).

FDA 97

FDA Vaccines Documentation Dosage 97

European Pharmaceutical Review

JULY 4, 2024

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 3 Is two too few? 3 Is two too few?

FDA 103

FDA Documentation Compounding Pharmaceutical Companies 103

The Thyroid Pharmacist

JULY 29, 2022

This article of mine discusses 19 thyroid-toxic products that have been banned by the FDA. Feel free to use my own health timeline as a guideline to document your health journey. 2018(1):1-10. doi: 10.1155/2018/4391579. Published 2018 Jul 2. Updated September 7, 2021. Accessed April 2022. Argunhan Z, Avci, AS.

Health and Personal Care Stores 52

Health and Personal Care Stores Compounding Immunization Labelling 52

ISPE

OCTOBER 28, 2022

The writing of requirements, design documentation, and test scripts, and the configuration of hardware and software, can be conducted from home. During the COVID-19 pandemic, the US FDA issued guidelines for remote evaluations of drug manufacturing and bioresearch facilities. Los Angeles, CA, US: Sage Publications, 2018.

Communication 52

Communication Documentation FDA 52

ISPE

SEPTEMBER 11, 2023

24 August 2018. Published 2018. FDA Official Warns Manufacturers of Common Problems Found in Aseptic Operations.” www.raps.org/news-and-articles/news-articles/2023/3/fda-official-warns-manufacturers-of-common-problem 25 US Food and Drug Administration Center for Drug Evaluation and Research. 6 November 2019. 7 March 2023.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

NOVEMBER 21, 2022

It was usual practice for TGA to prepare additional guidance/explanatory documents for industry and for TGA inspection staff to participate in training seminars to assist industry. Paul indicated that in 2018, ICMRA introduced an Inspection Reliance Guideline which was adopted by PIC/S. The approach by TGA and HSA were very similar.

FDA 52

FDA Vaccines Documentation Dosage 52

The Thyroid Pharmacist

JUNE 14, 2023

A 2015 case report documented the thyroid labs of a man who had recurrent hyperthyroid episodes after three of his wife’s pregnancies! September 27, 2018. Published 2018 Sep 3. Reviewed March, 2018. Like women, men can develop hormonal changes after the birth of a child, which can be linked to postpartum depression. [14]

Health and Personal Care Stores 111

Health and Personal Care Stores Immunization Documentation Compounding 111

ISPE

JULY 5, 2023

7 A critical feature of the ETP is representation from all relevant FDA quality assessment and inspection programs, from early engagement with stakeholders through application submission and assessment. 13 An FDA-authored paper indicating support for the implementation of CM using science- and risk-based approaches followed soon thereafter.

FDA 52

FDA Dosage Documentation Pharmaceutical Companies 52